Market cap
$14 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1 Mln
-
ROE
-0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
17
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
7,091,210
10 Years Aggregate
CFO
$824.30 Mln
EBITDA
$1,014.49 Mln
Net Profit
$768.28 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Forward Pharma A/S - ADR
| 31.3 | -14.7 | -14.7 | -52.1 | -25.8 | -33.5 | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Forward Pharma A/S - ADR
| -67.3 | -15.1 | 8.4 | 18.8 | -78.6 | -75.5 | -21.1 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Forward Pharma A/S - ADR
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological... indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Read more
-
Co-Founder & Chairman
Mr. Florian Schonharting M.Sc. (Econ)
-
Co-Founder & Chairman
Mr. Florian Schonharting M.Sc. (Econ)
-
Headquarters
Copenhagen
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Forward Pharma A/S - ADR
What is the current share price of Forward Pharma A/S - ADR Today?
The share price of Forward Pharma A/S - ADR is $2.56 (NASDAQ) as of 28-Feb-2023 09:30 EDT. Forward Pharma A/S - ADR has given a return of -25.85% in the last 3 years.
What is the current PB & PE ratio of Forward Pharma A/S - ADR?
Since, TTM earnings of Forward Pharma A/S - ADR is negative, P/E ratio is not available.
The P/B ratio of Forward Pharma A/S - ADR is 0.31 times as on 28-Feb-2023, a 94 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
2017 |
-- |
-- |
What is the 52 Week High and Low of Forward Pharma A/S - ADR?
The 52-week high and low of Forward Pharma A/S - ADR are Rs -- and Rs -- as of 01-Sep-2026.
What is the market cap of Forward Pharma A/S - ADR?
Forward Pharma A/S - ADR has a market capitalisation of $ 14 Mln as on 28-Feb-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Forward Pharma A/S - ADR?
Before investing in Forward Pharma A/S - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.